This HTML5 document contains 178 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
n13http://dx.doi.org/10.1007/
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n11http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
n12https://scigraph.springernature.com/pub.10.1007/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q37129663
rdf:type
wikibase:Item
schema:description
2010年學術文章 სამეცნიერო სტატია 2010年の論文 مقالة علمية نشرت في 26 أكتوبر 2010 ২০১০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 2010年學術文章 scienca artikolo scientific article published on 26 October 2010 2010年学术文章 наукова стаття, опублікована в жовтні 2010 vědecký článek 2010年学术文章 2010年學術文章 article scientifique (publié 2010) artigo científico (publicado na 2010) 2010年学术文章 научная статья artikulong pang-agham bài báo khoa học سائنسی مضمون 2010年學術文章 wissenschaftlicher Artikel 2010年学术文章 מאמר מדעי vetenskaplig artikel article scientific επιστημονικό άρθρο articol științific artículo científico publicado en 2010 naučni članak 2010年学术文章 article científic artykuł naukowy vitskapeleg artikkel 2010 nî lūn-bûn wetenschappelijk artikel tieteellinen artikkeli 2010年學術文章 artigo científico (publicado na 2010) vitenskapelig artikkel مقالهٔ علمی mokslinis straipsnis articolo scientifico videnskabelig artikel (udgivet 2010) научни чланак bilimsel makale мақолаи илмӣ գիտական հոդված บทความทางวิทยาศาสตร์ artículu científicu espublizáu en 2010 научна статия artikull shkencor 2010年學術文章 teaduslik artikkel vedecký článok научни чланак tudományos cikk мақолаи илмӣ artigo científico 2010년 논문
p:P577
wds:Q37129663-A98262E1-8D60-4AAE-994A-BC1DAFDD4093
wdt:P577
2010-10-26T00:00:00Z
p:P407
wds:Q37129663-AAB6B814-8BC0-4C8F-ABFE-EEE04E26E2C8
wdt:P407
wd:Q1860
p:P2888
wds:Q37129663-A2077B5F-BA9D-4E05-A6DD-8E3248699DC0
wdt:P2888
n12:s10549-010-1226-z
p:P2860
wds:Q37129663-FF1C1415-B69C-4B88-9A54-0FF93F10E406 wds:Q37129663-DC4BAC3A-AB95-48F9-885E-088DB253F7AB wds:Q37129663-DC59586D-5F71-4D84-8D53-6E653FE84E98 wds:Q37129663-E132E65B-D48B-4DA6-A15F-C0441F4DABA4 wds:Q37129663-C0463CD7-119A-4691-9A50-FAF9121E8616 wds:Q37129663-C9239716-5D01-460B-9B00-046C4C6410D1 wds:Q37129663-AFBA9944-630C-4773-9646-A419E6B2F405 wds:Q37129663-B62BCA5C-612A-4A0E-ADB8-F498C3CE6238 wds:Q37129663-AC87AFEB-C0BB-4799-8CA2-7F9F479B9F1D wds:Q37129663-AF7BF5DD-25BC-4065-9AC3-87DA462808C4 wds:Q37129663-9C28E91E-2C93-47CE-89BD-51E6EB93C964 wds:Q37129663-A0F1C4E9-F3E1-46A0-9469-FEE7CD53D12B wds:Q37129663-A5C8120C-B46E-4E49-82EB-2C86C5614E14 wds:Q37129663-62C3FFB3-C5A4-4C46-BEC0-1E831B831E58 wds:Q37129663-6AE8B519-91DE-43B2-8636-850727CFE3FD wds:Q37129663-80323E90-0265-4CC5-ACDE-B6073818EA47 wds:Q37129663-45587DC2-EBCF-4344-85E6-F159EF759426 wds:Q37129663-2F78314A-8518-4C65-A542-F093513BF637 wds:Q37129663-3C29CB69-186B-4BFA-BE77-F0201350C38E wds:Q37129663-401712B3-A67A-4642-AAB1-45E15BB4B55F wds:Q37129663-0C16E63A-F41D-4551-9174-D912A0222FCE wds:Q37129663-0E8873A4-2DEB-48FF-9AD9-038F909F2229 wds:Q37129663-1767FFF7-48A6-4EDD-874E-E685082BD865 wds:Q37129663-1E5206C3-BA74-4527-AD21-A81E4EABF7E5 wds:Q37129663-073922BE-9C9B-4699-9E29-DE93DA8AC041
wdt:P2860
wd:Q28282767 wd:Q44024840 wd:Q46412217 wd:Q43279296 wd:Q53426603 wd:Q46202262 wd:Q37588174 wd:Q29617585 wd:Q33630819 wd:Q27860904 wd:Q27861075 wd:Q72452835 wd:Q29617567 wd:Q36982859 wd:Q39754969 wd:Q33658626 wd:Q39921097 wd:Q37717889 wd:Q33364588 wd:Q29547625 wd:Q44591571 wd:Q37103086 wd:Q37331132 wd:Q40544950 wd:Q81364303
p:P2093
wds:Q37129663-6CAD1240-63E7-452F-9B40-358CC9708298 wds:Q37129663-907544EC-6A48-45A0-8D03-DC03F5ABD246 wds:Q37129663-D8126A00-7E17-4E54-BA7B-741DB485115C wds:Q37129663-C9C4307B-C85B-4CBD-82AA-A3AEDFE91D24 wds:Q37129663-B9724E78-D661-45B4-8AA6-B3E4B81023EB wds:Q37129663-C20B111C-71BE-434D-9947-0CD6A8599DC2 wds:Q37129663-EB8FC363-B682-4F03-853F-9207507F4352 wds:Q37129663-43CFB19F-A6D9-47A1-B6F8-787447E5E5C2 wds:Q37129663-5DB2C40B-59DD-40F0-A99E-D74BD99B10AE wds:Q37129663-54D80126-5C95-4900-8A40-C689935C3E7A wds:Q37129663-077A00D9-9C10-4E9A-89BD-ADC9198C87E1
wdt:P2093
Yvonne Ottaviano Philip Cohen Karen Creswell Mary Wilkinson Jennifer Eng-Wong Rebecca Slack Robert Warren Antonella Novielli Gina G Chung Karen L Smith Pia Herbolsheimer
rdfs:label
Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer
skos:prefLabel
Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer
schema:name
Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer
p:P50
wds:Q37129663-E902DC69-6582-4F4D-9B6D-DA014DB2A000 wds:Q37129663-99AB68B4-751C-4019-9E03-A7BBFF1BCAA6
wdt:P50
wd:Q89668739 wd:Q90579511
p:P1476
wds:Q37129663-D960B789-16F1-4E33-B594-D6263F05BF35
wdt:P1476
Phase I/II study of sorafenib with anastrozole in patients with hormone receptor positive aromatase inhibitor resistant metastatic breast cancer
p:P304
wds:Q37129663-603852AD-14C9-4974-A9B7-14A76598D95E
wdt:P304
137-143
p:P31
wds:Q37129663-8BDCC8B8-6D33-4EFD-BFA5-4DA335BE8B80
wdt:P31
wd:Q13442814
p:P921
wds:Q37129663-D1E0BC98-6BB1-4D32-BAE3-084295951282 wds:Q37129663-F9857CDE-A834-4BFB-A2AF-32AAFC74E0C6
wdt:P921
wd:Q419143 wd:Q12859063
p:P698
wds:Q37129663-060F2AE5-3845-4D0C-AA63-E06D7155942D
wdtn:P698
n11:20976541
wdt:P698
20976541
p:P1433
wds:Q37129663-956E7E97-1244-4D47-9BD3-D661EFE4362B
wdt:P1433
wd:Q326085
p:P433
wds:Q37129663-B8E52114-7D20-41F4-AF4D-0C256A14B3D1
p:P478
wds:Q37129663-01CA45F8-5B53-4C4A-AACA-34FFD7392457
wdt:P433
1
wdt:P478
125
p:P356
wds:Q37129663-E714A48D-EF8E-41D2-9E7A-D5441D18CAD7
wdtn:P356
n13:S10549-010-1226-Z
wdt:P356
10.1007/S10549-010-1226-Z
p:P5875
wds:Q37129663-04A36709-5100-4535-9650-7B1433DDFF97
wdt:P5875
47545923
p:P932
wds:Q37129663-BC5AE5D1-2AF7-42E0-A8CF-CB012DA083E2
wdt:P932
3756315